Literature DB >> 7707042

Suppression of programmed neuronal death by a thapsigargin-induced Ca2+ influx.

P A Lampe1, E B Cornbrooks, A Juhasz, E M Johnson, J L Franklin.   

Abstract

Rat sympathetic neurons undergo programmed cell death (PCD) in vitro and in vivo when they are deprived of nerve growth factor (NGF). Chronic depolarization of these neurons in cell culture with elevated concentrations of extracellular potassium ([K+]o) prevents this death. The effect of prolonged depolarization on neuronal survival is thought to be mediated by a rise of intracellular calcium concentration ([Ca2+]i) caused by Ca2+ influx through voltage-gated channels. In this report we investigate the effects of chronic treatment of rat sympathetic neurons with thapsigargin, an inhibitor of intracellular Ca2+ sequestration. In medium containing a normal concentration of extracellular Ca2+ ([Ca2+]o), thapsigargin caused a sustained rise of intracellular Ca2+ concentration and partially blocked death of NGF-deprived cells. Elevating [Ca2+]o in the presence of thapsigargin further increased [Ca2+]i, suggesting that the sustained rise of [Ca2+]i was caused by a thapsigargin-induced Ca2+ influx. This treatment potentiated the effect of thapsigargin on survival. The dihydropyridine Ca2+ channel antagonist, nifedipine, blocked both a sustained elevation of [Ca2+]i and enhanced survival caused by depolarization with elevated [K+]o, suggesting that these effects are mediated by Ca2+ influx through L-type channels. Nifedipine did not block the sustained rise of [Ca2+]i or enhanced survival caused by thapsigargin treatment, indicating that these effects were not mediated by influx of Ca2+ through L-type channels. These results provide additional evidence that increased [Ca2+]i can suppress neuronal PCD and identify a novel method for chronically raising neuronal [Ca2+]i for investigation of this and other Ca(2+)-dependent phenomena.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707042     DOI: 10.1002/neu.480260205

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  8 in total

Review 1.  Neural activity and survival in the developing nervous system.

Authors:  S Mennerick; C F Zorumski
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

2.  Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists.

Authors:  J L Nargi-Aizenman; D E Griffin
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Ca2+ influx in resting rat sensory neurones that regulates and is regulated by ryanodine-sensitive Ca2+ stores.

Authors:  Y M Usachev; S A Thayer
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

Review 4.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

5.  Glutamate inhibits GABA excitatory activity in developing neurons.

Authors:  A N van den Pol; X B Gao; P R Patrylo; P K Ghosh; K Obrietan
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 6.  Calcium signaling and cytotoxicity.

Authors:  G E Kass; S Orrenius
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

7.  Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation.

Authors:  Cristine Betzer; Louise Berkhoudt Lassen; Anders Olsen; Rikke Hahn Kofoed; Lasse Reimer; Emil Gregersen; Jin Zheng; Tito Calì; Wei-Ping Gai; Tong Chen; Arne Moeller; Marisa Brini; Yuhong Fu; Glenda Halliday; Tomasz Brudek; Susana Aznar; Bente Pakkenberg; Jens Peter Andersen; Poul Henning Jensen
Journal:  EMBO Rep       Date:  2018-03-29       Impact factor: 8.807

Review 8.  NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates.

Authors:  Yoshihiro Suzuki; Toshio Inoue; Chisei Ra
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.